WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 192
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 222

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported cases

(Click for retrospective incidence data for Niue)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  22 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Niue)
Vaccine year result method % card seen                                                
BCG          99*  92  99*  99*  99* 
DTP1          99*  99*  99*  99*  99* 
DTP3          99*  99*  99*  99*  99* 
DTP4          99*  99*  99* 
IPV1          99*  99*  99* 
HepB_BD          84  99*  99* 
HepB3          99*  99*  99*  99*  99* 
Hib3          99*  99*  99*  99*  99* 
JapEnc         
MCV1          99*  99*  99*  99*  99* 
MCV2          99*  99*  99*  99*  99* 
MenA         
PCV1          99*  99*  99*  99* 
PCV2          99*  99*  99*  99* 
PCV3          99*  99*  99*  99* 
Pol3          99*  99*  99*  99*  99* 
Rota1          99*  74 
RotaC          99*  74 
RCV1          99*  99*  99*  99* 
TT2plus          99* 
PAB          99* 
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Niue)
BCG
ChartChart
  99  99  99  99  99  99  85 
DTP1
ChartChart
  99  99  99  99  99  99  27 
DTP3
ChartChart
  99  99  99  99  99  99 
HepB3
ChartChart
  99  99  99  99  99 
HepB_BD
ChartChart
  99  99  99  99  99 
Hib3
ChartChart
  99  99  99  99  99 
MCV1
ChartChart
  99  99  99  99  99  99  77 
MCV2
ChartChart
  99  99  99  99  99 
PCV3
ChartChart
  99  99  99  99 
Pol3
ChartChart
  99  99  99  99  99  99  76 
RCV1
ChartChart
  99  99  99  99  99  99  77 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepIPV 6 weeks; 3, 5 months; Yes
DTaPIPV 4 years; Yes
HepB_Pediatric birth; Yes
HIB 15 months; Yes
Influenza_Adult 18-65 years; Yes and adults with chronic illness, health care workers, Haj or other travellers, other risk groups
Influenza_Pediatric Yes children with chronic illness
MMR 15 months; 4 years; Yes
Pneumo_conj 6 weeks; 3, 5, 15 months; Yes
Rotavirus 6 weeks; 3 months; Yes
Tdap 11 years; Yes
Varicella 15 months; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No    Yes    No  Yes  Yes 
What years does the MYP cover? number     2011-2021         
Nº of districts with microplans that include activities to raise immunization coverage number      

System performance

Total Nº districts in country number      
Nº districts with DTP3 coverage >=80% number    
% of districts with DTP3 coverage >=80% From 0 to 100% 100        100  100  100 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 100        100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No    No    Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No    No    No  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%          

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No    No    Yes  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.